Is BCAT undervalued? Intrinsic value estimate stands at $-0.0011.
Get informed when a big investor buys or sells
+ Follow$-0.00
Overvalued by 100.0% based on the discounted cash flow analysis.
BlackRock Capital Allocation Term Trust (BCAT) currently reports a DCF fair value of $-0.0011. Use the charts on this page to explore BlackRock Capital Allocation Term Trust's DCF fair value history and peer comparisons.
BlackRock Capital Allocation Term Trust's discounted cash flow (DCF) fair value estimate is $-0.0011, about 100.0% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $-0.0011, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BlackRock Capital Allocation Term Trust, and consider following BCAT for alerts when major investors trade the stock.